Pharmacology and drug discovery
Lessons learned from the contamination of heparin
Haiying Liu, Zhenqing Zhang and Robert J. Linhardt, Nat. Prod. Rep., 2009, 26, 313
DOI: 10.1039/b819896a
Natural products to drugs: natural product-derived compounds in clinical trials
Mark S. Butler, Nat. Prod. Rep., 2008, 25, 475
DOI: 10.1039/b514294f
Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs
Edmund I. Graziani, Nat. Prod. Rep., 2009, 26, 602
DOI: 10.1039/b804602f
Isolation, biology and chemistry of the disorazoles: new anti-cancer macrodiolides
Chad D. Hopkins and Peter Wipf, Nat. Prod. Rep., 2009, 26, 585
DOI: 10.1039/b813799b
Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
Carmen Cuevas and Andrés Francesch, Nat. Prod. Rep., 2009, 26, 322
DOI: 10.1039/b808331m
Design of biologically active heparan sulfate and heparin using an enzyme-based approach
Sherket Peterson, Amber Frick and Jian Liu, Nat. Prod. Rep., 2009, 26, 610
DOI: 10.1039/b803795g
Knipholone and related 4-phenylanthraquinones: structurally, pharmacologically, and biosynthetically remarkable natural products
Gerhard Bringmann, Joan Mutanyatta-Comar, Michael Knauer and Berhanu M. Abegaz, Nat. Prod. Rep., 2008, 25, 696
DOI: 10.1039/b803784c
